2 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Journal of the American Academy of Dermatology
Volume 74, n° 6
page 1254 (juin 2016)
Doi : 10.1016/j.jaad.2015.11.006
Research Letters

Thrombophilic status may predict prognosis in patients with metastatic BRAFV600-mutated melanoma who are receiving BRAF inhibitors

Anna Falanga, MD a, Marina Marchetti, PhD a, Daniela Massi, MD b, Barbara Merelli, MD c, Cristina Verzeroli, PhD a, Laura Russo, PhD a, Eliana Rulli, MSc d, Carlo Tondini, MD c, Lorenzo Legramandi, BSc d, Romina Nassini, PhD e, Cristian Scatena, MD b, Francesco De Logu, PhD e, Laura Cattaneo, MD f, Mario Mandalà, MD c,
a Department of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy 
c Unit of Medical Oncology, Hospital Papa Giovanni XXIII, Bergamo, Italy 
f Division of Pathological Anatomy, Hospital Papa Giovanni XXIII, Bergamo, Italy 
b Division of Pathological Anatomy, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy 
e Unit of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Florence, Italy 
d Department of Oncology, Clinical Research Laboratory, IRCCS - Istituto di Ricerche Farmacologiche “Mario Negri,” Milan, Italy 

Correspondence to: Mario Mandalà, MD, Unit of Medical Oncology, Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Piazza OMS 1, 24100, Bergamo, ItalyUnit of Medical OncologyDepartment of Oncology and HematologyPapa Giovanni XXIII HospitalPiazza OMS 1Bergamo24100Italy

 This work is supported by grants of the Italian Association for Cancer Research (AIRC) (IG2013 Ref. 14505; AIRC “5xMILLE” n. 12237).
 Conflicts of interest: None declared.

Top of the page

© 2016  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline
You can move this window by clicking on the headline